Increasing evidence shows that PAK1 is overexpressed in pancreatic cancer patients, and the deregulation of PAK1 contributes to increased cancer cell survival, proliferation, migration and Gem resistance [28,29,30]. This evidence concerns the gene PAK1 and cancer.